Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
02-26

DJ Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bio-Techne Corp. $(TECH)$ slid 2.04% to $64.22 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.37% to 43,621.16 and the S&P 500 Index falling 0.47% to 5,955.25.

Bio-Techne Corp. closed 24.95% below its 52-week high of $85.57, which the company achieved on May 15th.

The stock underperformed when compared to some of its competitors Tuesday, as Amgen Inc. $(AMGN)$ rose 1.91% to $315.63, Charles River Laboratories International Inc. $(CRL)$ fell 2.00% to $167.10, and BioMarin Pharmaceutical Inc. $(BMRN)$ rose 3.14% to $71.17.

Trading volume (1.7 M) eclipsed its 50-day average volume of 1.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 25, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

February 25, 2025 17:20 ET (22:20 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10